A detailed history of Alpha Dna Investment Management LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 2,332 shares of KRYS stock, worth $384,383. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,332
Previous 2,558 8.84%
Holding current value
$384,383
Previous $469,000 9.59%
% of portfolio
0.16%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$174.7 - $213.66 $39,482 - $48,287
-226 Reduced 8.84%
2,332 $424,000
Q2 2024

Aug 14, 2024

SELL
$153.12 - $183.64 $63,238 - $75,843
-413 Reduced 13.9%
2,558 $469,000
Q1 2024

May 15, 2024

BUY
$108.01 - $179.35 $320,897 - $532,848
2,971 New
2,971 $528,000

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.23B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.